| Literature DB >> 16763589 |
Abstract
Compared with the plethora of financial information about the publicly traded elite of the biotech world, little is known about the multitude of private biotech firms. Here, Nature Biotechnology's Editor-at-Large provides an analysis of the financial performance of the privately held biotech sector.Mesh:
Year: 2006 PMID: 16763589 DOI: 10.1038/nbt0606-635
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908